1. Home
  2. OPRX vs DERM Comparison

OPRX vs DERM Comparison

Compare OPRX & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OptimizeRx Corporation

OPRX

OptimizeRx Corporation

HOLD

Current Price

$12.18

Market Cap

258.2M

ML Signal

HOLD

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$8.02

Market Cap

210.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRX
DERM
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
258.2M
210.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
OPRX
DERM
Price
$12.18
$8.02
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$19.67
$12.67
AVG Volume (30 Days)
241.3K
129.3K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$109,506,000.00
$59,399,000.00
Revenue This Year
$19.77
$17.48
Revenue Next Year
$11.33
$55.83
P/E Ratio
$6,661.29
N/A
Revenue Growth
24.18
2.82
52 Week Low
$3.99
$3.54
52 Week High
$22.25
$9.40

Technical Indicators

Market Signals
Indicator
OPRX
DERM
Relative Strength Index (RSI) 39.13 53.99
Support Level $12.23 $7.15
Resistance Level $13.00 $8.40
Average True Range (ATR) 0.79 0.41
MACD 0.04 0.08
Stochastic Oscillator 16.39 72.03

Price Performance

Historical Comparison
OPRX
DERM

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Share on Social Networks: